Healthcare provider profile · identity verified

Ellen M Kim, MD

Internal Medicine · RICHLAND, WA · NPI 1124024229

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	843	238
Amlodipine Besylate	Amlodipine Besylate	506	143
Losartan Potassium	Losartan Potassium	481	138
Levothyroxine Sodium	Levothyroxine Sodium	465	124
Gabapentin	Gabapentin	389	90
Lisinopril	Lisinopril	372	111
Omeprazole	Omeprazole	344	78
Tamsulosin Hcl	Tamsulosin Hcl	227	62
Metoprolol Succinate	Metoprolol Succinate	219	68
Metformin Hcl	Metformin Hcl	198	58
Trazodone Hcl	Trazodone Hcl	187	45
Hydrochlorothiazide	Hydrochlorothiazide	167	45
Rosuvastatin Calcium	Rosuvastatin Calcium	161	36
Escitalopram Oxalate	Escitalopram Oxalate	147	35
Meloxicam	Meloxicam	141	32
Simvastatin	Simvastatin	141	34
Jardiance	Empagliflozin	133	39
Metformin Hcl Er	Metformin Hcl	132	48
Famotidine	Famotidine	130	35
Pantoprazole Sodium	Pantoprazole Sodium	122	31
Ozempic	Semaglutide	121	25
Eliquis	Apixaban	116	30
Tramadol Hcl	Tramadol Hcl	115	30
Duloxetine Hcl	Duloxetine Hcl	114	28
Tizanidine Hcl	Tizanidine Hcl	112	28
Albuterol Sulfate Hfa	Albuterol Sulfate	111	45
Potassium Chloride	Potassium Chloride	110	23
Furosemide	Furosemide	105	30
Sertraline Hcl	Sertraline Hcl	105	34
Fluticasone Propionate	Fluticasone Propionate	100	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	20
Metoprolol Tartrate	Metoprolol Tartrate	87	19
Montelukast Sodium	Montelukast Sodium	87	20
Clopidogrel	Clopidogrel Bisulfate	86	24
Allopurinol	Allopurinol	84	24
Buspirone Hcl	Buspirone Hcl	80	18
Pravastatin Sodium	Pravastatin Sodium	80	23
Fluoxetine Hcl	Fluoxetine Hcl	75	16
Paroxetine Hcl	Paroxetine Hcl	75	20
Carvedilol	Carvedilol	72	21
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	69	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	18
Zolpidem Tartrate	Zolpidem Tartrate	64	15
Alendronate Sodium	Alendronate Sodium	61	20
Bupropion Xl	Bupropion Hcl	59	20
Donepezil Hcl	Donepezil Hcl	58	18
Pregabalin	Pregabalin	57	12
Fenofibrate	Fenofibrate	56	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	55	14
Baclofen	Baclofen	54	18
Trulicity	Dulaglutide	53	11
Acyclovir	Acyclovir	52	16
Finasteride	Finasteride	50	13
Glipizide Er	Glipizide	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	13
Glimepiride	Glimepiride	48	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	17
Ezetimibe	Ezetimibe	47	14
Ipratropium Bromide	Ipratropium Bromide	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	15
Mirtazapine	Mirtazapine	45	11
Atenolol	Atenolol	43	13
Lovastatin	Lovastatin	43	11
Synthroid	Levothyroxine Sodium	42	13
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Xarelto	Rivaroxaban	41	suppressed
Estradiol	Estradiol	40	15
Triamcinolone Acetonide	Triamcinolone Acetonide	40	28
Januvia	Sitagliptin Phosphate	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	11
Azithromycin	Azithromycin	34	30
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Cephalexin	Cephalexin	33	25
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Methocarbamol	Methocarbamol	31	13
Lorazepam	Lorazepam	30	15
Valacyclovir	Valacyclovir Hcl	30	11
Valsartan	Valsartan	30	11
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Temazepam	Temazepam	29	suppressed
Topiramate	Topiramate	29	suppressed
Varenicline Tartrate	Varenicline Tartrate	29	suppressed
Mounjaro	Tirzepatide	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Ramipril	Ramipril	27	suppressed
Prednisone	Prednisone	26	16
Fluconazole	Fluconazole	25	19
Farxiga	Dapagliflozin Propanediol	24	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	14
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Nystatin	Nystatin	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	19
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Glipizide	Glipizide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Primidone	Primidone	19	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lactulose	Lactulose	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Ketoconazole	Ketoconazole	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Telmisartan	Telmisartan	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Torsemide	Torsemide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Linzess	Linaclotide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error